THW, C., L, A., C, B., E, D., J, E., T, E., . . . B, K. (2024). Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. Frontiers in psychiatry, 15, 1372373. https://doi.org/10.3389/fpsyt.2024.1372373
Chicago Style (17th ed.) CitationTHW, Ching, et al. "Corrigendum: Safety, Feasibility, Tolerability, and Clinical Effects of Repeated Psilocybin Dosing Combined with Non-directive Support in the Treatment of Obsessive-compulsive Disorder: Protocol for a Randomized, Waitlist-controlled Trial with Blinded Ratings." Frontiers in Psychiatry 15 (2024): 1372373. https://doi.org/10.3389/fpsyt.2024.1372373.
MLA (9th ed.) CitationTHW, Ching, et al. "Corrigendum: Safety, Feasibility, Tolerability, and Clinical Effects of Repeated Psilocybin Dosing Combined with Non-directive Support in the Treatment of Obsessive-compulsive Disorder: Protocol for a Randomized, Waitlist-controlled Trial with Blinded Ratings." Frontiers in Psychiatry, vol. 15, 2024, p. 1372373, https://doi.org/10.3389/fpsyt.2024.1372373.
